Mary Anderson’s lifelong commitment to innovation, education and advocacy improves the lives of patients and empowers her ...

Many men with metastatic hormone-sensitive prostate cancer have not received recommended first-line therapies due to clinicians’ unfamiliarity with treatment guidelines and misinformation about ...

Pediatric patients with high-risk neuroblastoma had significantly lower 5-year survival rates in induction and/or ...

UnityPoint Health celebrated the expansion of the Cancer Center in Moline. The work renovated more than 10,000 square feet of space. The updates include installing more infusion chairs, adding new ...

Trinity officials said the $14 million project will better serve the growing number of patients requiring cancer care in the ...

Johnson & Johnson has generated evidence that the pace of oncology innovation is overwhelming physicians. | Johnson & Johnson ...

The Food and Drug Administration (FDA) has approved Imfinzi ® (durvalumab), in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single agent Imfinzi as adjuvant ...

The National Comprehensive Cancer Network hosted an Oncology Policy Summit in Washington, D.C., today, focused on improving ...

UnityPoint Health proudly celebrates a $14 million investment in cancer care, designed to meet the growing need for ...

Experts at the Community Oncology Conference discuss innovative patient navigation programs, emphasizing technology's role ...

Experts emphasize the need for enhanced clinical trial infrastructure in community oncology to ensure equitable access to ...